2009-February Archives by Subject

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...

Starting: Mon Feb 2 16:11:01 2009
Ending: Fri Feb 27 15:07:16 2009
Messages: 80

• [Ip-health] IP Watch: Strong EU Trade Provisions On IP See n As Threat To Poor Nations’ Medicines Access   Judit Rius Sanjuan
• [Ip-health] IPLeft Statement Roche’s Proposal of Compassionate Access Programme for HIV/AIDS Patients in South Korea   Heesob Nam
• [Ip-health] Achieving Innovation + Access in Global Pharmaceutical Markets   Michael Palmedo
• [Ip-health] ACTA, an example of global democracy deficit - the secret treaty negotiation   James Love
• [Ip-health] Anti-counterfeiting: Policy of encirclement   Sangeeta
• [Ip-health] CA Atty Gen sues pharm for colluding to delay generic entry; Senators introduce legislation banning same   Jay Purcell
• [Ip-health] Cipla files post grant opposition against Tykerb/Lapatinib GSK patent   Judit Rius Sanjuan
• [Ip-health] Civil society organizes for access to LPV/r (Kaletra) and compulsory licenses in Latin America   peter maybarduk
• [Ip-health] Classified ACTA Documents Reveal Disagreements Among Participants   James Love
• [Ip-health] Companies lobby to secure patents in Antarctica   Sangeeta
• [Ip-health] Details emerge of secret ACTA negotiation   James Love
• [Ip-health] Dutch drug seisures: TACD letter to European Commission   Malini Aisola
• [Ip-health] EU-ASEAN FTA - draft IPR chapter (April 2008)   jiraporn
• [Ip-health] EU-ASEAN PROPOSALS ON INTELLECTUAL PROPERTY TOO SWEEPING, SAY CONSUMERS   Kar K.
• [Ip-health] EU-ASEAN Text on IPR   tui
• [Ip-health] Event Memo from Health Action International- Expert Meeting at the European Parliament   Terri - Louise Beswick
• [Ip-health] EXPERT MEETING: THE EU-CAN ASSOCIATION AGREEMENT - ACCESS TO MEDICINES IN JEOPARDY!   Terri - Louise Beswick
• [Ip-health] Feb 19: Achieving Innovation + Access in Global Pharmaceutical Markets   Mike Palmedo
• [Ip-health] Firms' secret tax avoidance schemes cost UK billions   Miles Teg
• [Ip-health] Global Health and Innovation Conference at Yale   Jennifer Staple
• [Ip-health] GSK Access to Medicines: The Good, the Bad, and the Illusory   B.Baker@neu.edu
• [Ip-health] Guardian, UK: Drug giant GlaxoSmithKline pledges cheap medicine for world's poor   Malini Aisola
• [Ip-health] Guardian: MSF response to GSK - This prescription for change needs to go much further   James ARKINSTALL
• [Ip-health] India - Generics face patent barrier - (First to Brazil - now Peru)   Sangeeta
• [Ip-health] India moves to protect traditional medicines from foreign patents   Ira Glazer
• [Ip-health] India, Brazil to take on EU over regulation   Sangeeta
• [Ip-health] Indian intervention at WTO on seizure of drug consignments   Sangeeta
• [Ip-health] Intellectual Property Watch: Concern Erupts Over WTO System And Medicines Shipments;TRIPS Talks Rekindling   IP Watch
• [Ip-health] Intervention by Brazil at WTO General Council on seizure of 500 kilos of generic medicines by Dutch customs authorities   Thiru Balasubramaniam
• [Ip-health] Intervention by the European Communities (EC) at WTO General Council on the seizure of losartan by Dutch customs authorities   Thiru Balasubramaniam
• [Ip-health] IP-Watch: International Health Groups Warn WHO, WTO On Medicines Seizures   Thiru Balasubramaniam
• [Ip-health] J Barton on Access + Innovation Tonight   Sean Flynn
• [Ip-health] James Love in The Huffington Post: Obama Administration Embraces Corporate Lobbyists on IP Issues in Geneva   Thiru Balasubramaniam
• [Ip-health] KEI reaction to GSK announcement on patent pool for neglected diseases   James Love
• [Ip-health] Lancet: Trade, TRIPS, and pharmaceuticals   Matt Price
• [Ip-health] Launching the Nairobi Seminars on Development Research (NSDR)   Sisule F. Musungu
• [Ip-health] Losartan: seizure in the Netherlands, marketing in Switzerland   Patrick Durisch
• [Ip-health] MSF letters to EC after seizure of legitimate generics under EC customs Regulations   James ARKINSTALL
• [Ip-health] MSF response to GSK announcement   James ARKINSTALL
• [Ip-health] MSF statement on launch of G-FINDER report on R&D   James ARKINSTALL
• [Ip-health] Netherlands assures India to sort out drug seizure issue   Sandeep.Rathod@matrixlabsindia.com
• [Ip-health] New study: Decline of University Patenting and the End of the Bayh-Dole Effect   Suerie Moon
• [Ip-health] News reports indicate that the EU does drop demands for data exclusivity if the other party resists   Sanya Reid Smith
• [Ip-health] NFTC Launches Global Innovation Forum   James Love
• [Ip-health] No binary Attachments on ip-health   James Love
• [Ip-health] Obama Appoints AIDS Policy Chief   Ben Krohmal
• [Ip-health] Obama planning to take on health insurance, drug companies to finance health care reform   Sarah Rimmington
• [Ip-health] Patent pools for medicines: MSF in Chatham House   James ARKINSTALL
• [Ip-health] PharmaTimes: EU anti-counterfeiting rules "being misused by pharma corporate criminals"   Thiru Balasubramaniam
• [Ip-health] PhRMA 2009 Special 301 Submission   Judit Rius Sanjuan
• [Ip-health] PIJIP/KEI Panel on Barton/Pfizer Proposal for Price Discrimination in Middle and Low-Income Nations   Michael Palmedo
• [Ip-health] Pointing the finger at Big Pharma - Dutch seizure of generic medicines   B.Baker@neu.edu
• [Ip-health] Press advisory on NGO letters to WHO and WTO on Dutch seizures of generic medicines   James Love
• [Ip-health] RE: [A2k] USTR Request for Comments for 2009 Special 301 Report   Dalindyebo Bafana Shabalala
• [Ip-health] Re: Can India, Brazil take on EU over regulation?   Daya Shanker
• [Ip-health] Re: Civil society organizes for access to LPV/r (Kaletra) and compulsory licenses in Latin America   peter maybarduk
• [Ip-health] RE: Ip-health digest, Vol 1 #2785 - 1 msg   KangAra
• [Ip-health] Re: Request for Compulsory License on Fuzeon Patent   Heesob Nam
• [Ip-health] Reuters - GSK proposes patent pool for neglected diseases   James ARKINSTALL
• [Ip-health] Roche's programme for Fuzeon supply in Korea   Heesob Nam
• [Ip-health] Science: Tangled Patent Dispute Over 'Free' Drug-Resistance Database   Matt Price
• [Ip-health] Senate Finance to Take Up U.S. Trade Negotiator Nominee   Sarah Rimmington
• [Ip-health] Skepticism about the Barton/Pfizer Access-to-Medicines Pricing Proposal   B.Baker@neu.edu
• [Ip-health] Soaring Cancer Drug Costs May Cripple Medicare   Joana Ramos
• [Ip-health] Some data points on Senator Judd Gregg   James Love
• [Ip-health] submission   THD Blog
• [Ip-health] Synexus extends patient outreach through GP sales force   Joana Ramos
• [Ip-health] TACD letters on seizures of generic medicines by the Dutch customs authorities   Anne-Catherine Lorrain
• [Ip-health] Teva Launches Year of Affordable Healthcare   info@yearofaffordablehealth.com
• [Ip-health] The Guardian: Profits before the poor? Drugs giant offers an answer to the toxic question facing a 'heartless' industry   Thiru Balasubramaniam
• [Ip-health] TWN INFO: Developing countries attack Dutch seizure of generic medicines   Sangeeta
• [Ip-health] TWN Info: NGOs voice concerns to WHO, WTO on seizure of generic drugs   Sangeeta
• [Ip-health] U.S. to Compare Treatments   Miles Teg
• [Ip-health] UNCTAD-ICTSD Roundtable: The US-China Panel Report and the Future of IPRs Enforcement.23.Feb.09   Ahmed Abdel Latif
• [Ip-health] UNITAID NGO delegation: Call for applications for NGO alternate board member   Judit Rius Sanjuan
• [Ip-health] UNITAID Statement on GSK Patent Pool For Neglected Diseases   Thiru Balasubramaniam
• [Ip-health] USTR Request for Comments for 2009 Special 301 Report   Mike Palmedo
• [Ip-health] Wall Street Journal Health Blog: Sanofi-Aventis Set to Join Pharma Acquisition Party   Thiru Balasubramaniam
• [Ip-health] Webcast of event with Prof. John Barton   Malini Aisola
• [Ip-health] WSJ: Glaxo Plans to Cut Drug Prices in Poorest Countries   Malini Aisola

Last message date: Fri Feb 27 15:07:16 2009
Archived on: Fri Feb 27 15:07:17 2009

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...